arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

MetaVia Inc.

MTVA
$1.07 ▼ -0.29 (-21.32%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
47 Visible periods
20 Metrics
Peer-ranked Benchmarks
Price Chart
22
Health
Poor
Bearish
auto_awesome

Analytical Summary

MetaVia Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $6.3M
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC -78.9% ↘
FCF / Share $-0.63 ↗
Trailing P/E —
Price / Book 1.0x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

47-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-3.82M
↓ -4.1% —
FCF / Share Free cash flow per share
$-0.63
↑ +27.6% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
1
Cash Quality ↑
73

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 13 years · 47 quarters